🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesAnti-thrombotic properties of GLP-1 receptor activation — looking for input Page 5

Anti-thrombotic properties of GLP-1 receptor activation — looking for input

robert_kc Wed, Apr 16, 2025 at 7:30 AM 26 replies 1,964 viewsPage 5 of 6
mona_PHX
Member
189
890
Dec 2024
Phoenix, AZ
May 1, 2025 at 4:40 PM#21

A narrower follow-up, since the general answer is now clear:

What did you change at the same time, and can you separate the two now?

21 19RetaRick_CA, JenPlateau, SallyK_inj and 18 others
Reply Quote Save Share Report
SleepFixSam
Member
212
678
Nov 2024
Hawaii
May 7, 2025 at 5:44 AM#22
mike_nyc said:
It helps to ask what evidence would change your mind before you look at any.

I read this differently from mike_nyc, on substance rather than tone. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

22 20ingrid_STO, pete_nash, hank_denver and 19 others
Reply Quote Save Share Report
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
May 12, 2025 at 6:45 PM#23
mike_nyc said:
It helps to ask what evidence would change your mind before you look at any.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

23 21paul_denver, TinaHashiRN, robert_kc and 20 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.ObesityMed
VIP Member
3,456
19,234
Nov 2023
Denver, CO
Online
May 18, 2025 at 7:43 AM#24
mike_nyc said:
It helps to ask what evidence would change your mind before you look at any.

Bookmarking. The distinction being drawn above is the one nobody else makes. Sending this to two other people who asked me the same thing last week.

24 22PeptideChemSF, A1cHero_PHX, Dr.RenalNash and 21 others
Reply Quote Save Share Report
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
May 23, 2025 at 8:38 PM#25

From the other side of the consultation, briefly. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

25 23Dr.LipidDallas, alex_tucson, kevin_tulsa and 22 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register